Back to Authors

Habermann, Thomas M.

Mayo Clinic

Mayo Clinic

Citations 3

Clinicopathological and Gene Expression Analysis of Hyaline Vascular Castleman Disease
Nishimura, Midori Filiz , Iwamoto, Yuika, Haratake, Tomoka , Ujiie, Hideki , Nishikori, Asami , Habermann, Thomas M., Nishimura, Yoshito , Iwamoto, Yuika, Habermann, Thomas M. , Dispenzieri, Angela , Sato, Yasuharu

Blood | December 6, 2024 | Volume: 144 | Issue: Supplement 1 | Pages: 3301-3301

10.1182/blood-2024-200298 Get It

Introduction: Hyaline-vascular type unicentric Castleman disease (HV-UCD) is a classic variant of Castleman disease, characterized by localized lymph node hyperplasia. Due to its rarity, there have been few systematic reports summarizing its clinicopathological features globally. Also, its pathogenesis remains unelucidated. The present study aims to provide a detailed clinicopathological and transcriptomic analysis of HV-UCD to enhance the understanding of its underlying mechanisms at a molecular level. Methods: We conducted a clinicopathological analysis of 51 HV-UCD cases and performed whole transcriptome analysis on frozen lymph node specimens from four cases. Differentially expressed genes (DEGs) and Gene Ontology (GO) analyses were performed to identify significant pathways and biological processes involved in HV-UCD, with reactive lymphoid hyperplasia as control. Results: The mean age of HV-UCD patients was 42.8 years, with no significant gender differences. The most common sites involved were the abdominal cavity (n = 18, 35.3%), mediastinum (n = 11, 21.6%), and retroperitoneum (n = 9, 17.6%), with an average size of the lesions being 4.8 cm. Histologically, 33.3% of cases exhibited “dysplastic follicular dendritic cells (dFDCs)” characterized by multinucleation or large nuclei within and outside follicles, positive for follicular dendritic cells (FDC) markers. DEGs analysis compared to reactive lymphoid hyperplasia revealed significant upregulation of genes related to FDCs and angiogenesis. Notably, the placental growth factor (PGF), a proangiogenic factor and a member of the VEGF family, demonstrated significant overexpression. GO analysis identified significant enrichment of genes involved in angiogenesis, cell adhesion, tissue architecture, and humoral immunity. Discussion: This large cohort of HV-UCD cohort provides potentially novel clinicopathological insights. Gene expression analysis demonstrated increased expression of FDC-related genes, suggesting a pivotal role of FDCs in HV-UCD pathogenesis. The differences in the gene profiles related to angiogenesis may contribute to the distinct mechanisms and histological features of HV-UCD and iMCD-TAFRO, where HV-UCD is associated with hyalinization of vascular walls and iMCD-TAFRO is characterized by angiogenesis with endothelial cell swelling. Conclusion: The present results suggest the crucial role of FDCs in HV-UCD pathogenesis from the molecular features. Currently, there are no objective diagnostic markers for HV-UCD. Identifying these markers may lead to a clearer understanding of the disease pathophysiology and improve diagnostic accuracy for HV-UCD. Further investigation is warranted to verify the findings.
Clinicopathological Features of Kikuchi-Fujimoto Disease: Retrospective Observational Study
Nishimura, Midori Filiz , Sakao, Chikako, Nishikori, Asami , Habermann, Thomas M., Nishimura, Yoshito , Habermann, Thomas M. , Dispenzieri, Angela , Sato, Yasuharu

Blood | December 5, 2024 | Volume: 144 | Issue: Supplement 1 | Pages: 5371-5371

10.1182/blood-2024-200286 Get It

Introduction: Kikuchi-Fujimoto disease (KFD), is a rare inflammatory disease of unknown etiology, typically presenting with transient fever and cervical lymphadenopathy. It is recently classified as a tumor-like lesion in the World Health Organization Classification 5th Edition. There are few large-scale studies on patient demographics and clinical course. This study aims to report detailed clinicopathological features of KFD. Methods: We reviewed 112 cases of KFD diagnosed at Okayama University Department of Pathology and Oncology, Okayama, Japan between 2012 and 2022. Patients who were diagnosed with autoimmune diseases or bacterial/tuberculous lymphadenitis after the initial presentation as KFD were excluded. Results: The average age of the included cases was 29.4 years (range:6 to 77 years) with slight female predominance (n = 51/115, 44.3% for male; n = 61/115, 53.0% for female). For the included cases of 30 years or older, there were more females than males. The cervical lymph nodes were the most commonly affected sites (85%). For the 70 patients who had complete follow-up data available in the electric medical records, the recurrence rate was 23%, without a difference between males and females. Laboratory tests demonstrated significantly lower complement 4 (C4) levels (p = 0.038) and a higher rate of positive antinuclear antibodies (p = 0.007) in the relapsed cases than in the cases without documented recurrence. The mean number of days prior to confirm the diagnosis was 71.5 days. Among the representative lymph node histology classification, proliferative type was the most common (n = 75; 77%), followed by necrotizing (n = 22; 22%), and xanthomatous (n = 1; 1%). The patients with necrotizing type had significantly enlarged lymph nodes (p = 0.047) and longer duration of symptoms (p = 0.009) compared to the proliferating type. Discussion: The present study provides data from a large KFD cohort to provide comprehensive clinicopathological information to date. While KFD is known to predominantly affect female, there were considerably more males up to age 30 than females, Being young and adolescent male KFD patients was associated with atypical features. Future studies are warranted to confirm the findings noted in the results, to clarify clinicopathological differences in the male young adolescent KFD, and further characterize the classical female KFD cases, including histological features, treatment responses, and association with autoimmune or malignant hematology conditions. Conclusion: In this study, we analyzed a large number of KFD cases and clarified characteristics. The comprehensive clinicopathological features provided by the present results may be useful in elucidating the pathogenesis and predicting the clinical course of such clinically challenging cases, including association with autoimmune diseases and its long-term outcomes.
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Bachy, Emmanuel , Habermann, Thomas M., Gelas‐Dore, Bénédicte, Estell, Jane, Neste, Éric Van Den, Bouabdallah, Réda, Gyan, Emmanuel , Bargay, Joan , Slager, Susan L., Silva, María Gomes da , Fitoussi, Olivier , Intragumtornchai, Tanin , Ansell, Stephen M., Lamy, T. , Dartigues, Peggy , Link, Brian K. , Seymour, John F., Salles, Gilles , Link, Brian K , Gyan, Emmanuel , Salles, Gilles A , Maurer, Matthew J. , Habermann, Thomas M. , Maucort‐Boulch, Delphine , Feldman, Andrew L. , Delmer, Alain , Slager, Susan L. , Belada, David , Maisonneuve, Hervé , Ansell, Stephen M. , Cerhan, James R. , Bachy, Emmanuel

Blood | April 17, 2018 | Volume: 132 | Issue: 1 | Pages: 49-58

10.1182/blood-2017-11-816405 Get It

Key Points In FL, no prognostic index has been built based solely on a large cohort of patients treated with initial immunochemotherapy. The PRIMA-PI is a simplified index based on β2m and bone marrow involvement for patients treated with immunochemotherapy.